These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22526844)

  • 41. Clinical phenotype of Gaucher disease in relation to properties of mutant glucocerebrosidase in cultured fibroblasts.
    Van Weely S; Van Leeuwen MB; Jansen ID; De Bruijn MA; Brouwer-Kelder EM; Schram AW; Sa Miranda MC; Barranger JA; Petersen EM; Goldblatt J
    Biochim Biophys Acta; 1991 Jun; 1096(4):301-11. PubMed ID: 1829642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.
    Lepe-Balsalobre E; Santotoribio JD; Nuñez-Vazquez R; García-Morillo S; Jiménez-Arriscado P; Hernández-Arévalo P; Delarosa-Rodríguez R; Guerrero JM; Macher HC
    Clin Chem Lab Med; 2020 Jun; 58(12):2017-2024. PubMed ID: 32589593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the Zebrafish Homolog of β-Glucosidase 2: A Target of the Drug Miglustat.
    Sultana S; Truong NY; Vieira DB; Wigger JG; Forrester AM; Veinotte CJ; Berman JN; van der Spoel AC
    Zebrafish; 2016 Jun; 13(3):177-87. PubMed ID: 26909767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.
    Bergmann JE; Grabowski GA
    Am J Hum Genet; 1989 May; 44(5):741-50. PubMed ID: 2495719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Properties of the molecular forms of beta-glucosidase and beta-glucocerebrosidase from normal human and Gaucher disease spleen (author's transl)].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Eur J Biochem; 1981 Apr; 115(3):455-61. PubMed ID: 6786882
    [No Abstract]   [Full Text] [Related]  

  • 46. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
    Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM
    Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucocerebrosidase, a new player changing the old rules in Lewy body diseases.
    Yang NY; Lee YN; Lee HJ; Kim YS; Lee SJ
    Biol Chem; 2013 Jul; 394(7):807-18. PubMed ID: 23435096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assay of the beta-glucosidase activity with natural labelled and artificial substrates in cultivated skin fibroblasts from homozygotes and heterozygotes with the Norrbottnian type of Gaucher disease.
    Håkansson G; Dreborg S; Lindsten J; Svennerholm L
    Clin Genet; 1980 Oct; 18(4):268-73. PubMed ID: 6777099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-Glucosidase isoenzymes in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with type 1 Gaucher disease.
    Maret A; Salvayre R; Samadi M; Douste-Blazy L
    Enzyme; 1987; 37(4):208-17. PubMed ID: 3038513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
    Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
    Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative properties of the three groups of splenic beta-glucosidase molecular forms.
    Salvayre R; Maret A; Negre A; Douste-Blazy L
    Prog Clin Biol Res; 1982; 95():443-52. PubMed ID: 6812080
    [No Abstract]   [Full Text] [Related]  

  • 53. ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease.
    Maor G; Filocamo M; Horowitz M
    Hum Mol Genet; 2013 Apr; 22(7):1316-27. PubMed ID: 23255161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
    van Weely S; van den Berg M; Barranger JA; Sa Miranda MC; Tager JM; Aerts JM
    J Clin Invest; 1993 Mar; 91(3):1167-75. PubMed ID: 8450045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
    Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced pluripotent stem cell line (INSAi001-A) from a Gaucher disease type 3 patient compound heterozygote for mutations in the GBA1 gene.
    Duarte AJ; Ribeiro D; Santos R; Moreira L; Bragança J; Amaral O
    Stem Cell Res; 2019 Dec; 41():101595. PubMed ID: 31678773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene".
    Gravel RA; Leung A
    Hum Genet; 1983; 65(2):112-6. PubMed ID: 6418635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
    Goldin E; Zheng W; Motabar O; Southall N; Choi JH; Marugan J; Austin CP; Sidransky E
    PLoS One; 2012; 7(1):e29861. PubMed ID: 22272254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation).
    Zimmer KP; le Coutre P; Aerts HM; Harzer K; Fukuda M; O'Brien JS; Naim HY
    J Pathol; 1999 Aug; 188(4):407-14. PubMed ID: 10440752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease.
    Mistry PK; Liu J; Sun L; Chuang WL; Yuen T; Yang R; Lu P; Zhang K; Li J; Keutzer J; Stachnik A; Mennone A; Boyer JL; Jain D; Brady RO; New MI; Zaidi M
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4934-9. PubMed ID: 24639522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.